haematology
Blood cancers

Back to school advice for paediatric oncology and BMT patients

As schools reopen it should be safe for most immunosuppressed paediatric oncology patients to return to the classroom, according to advice from the Australia and New Zealand Children’s Haematology/Oncology Group (ANZCHOG). However the group acknowledges that return to school decisions in relation to COVID-19 risk are complex for families of children who are receiving or ...

Already a member?

Login to keep reading.


OR
© 2020 the limbic